Abstract
Background Identification of non-invasive serum fibrosis markers in liver disease is challenging. We aimed to identify a new marker panel for the identification of significant fibrosis in a large cohort of patients with chronic liver disease with mixed aetiology.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
